bioAffinity Technologies, Inc. (BIAFW) Operating cash flow 2021–2025
bioAffinity Technologies, Inc. (BIAFW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.3MFY2025 · since FY2021: -$2.0M → -$9.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.3M | -28.4% |
| FY2024 | -$7.3M | -20.3% |
| FY2023 | -$6.0M | -48.3% |
| FY2022 | -$4.1M | -98.7% |
| FY2021 | -$2.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAFW financial trends
BIAFW RevenueBIAFW Net incomeBIAFW Net marginBIAFW Gross profitBIAFW Gross marginBIAFW Operating incomeBIAFW Operating marginBIAFW Free cash flowBIAFW Capital expendituresBIAFW Return on equityBIAFW Stock buybacksBIAFW Dividends paidBIAFW Total assetsBIAFW Total liabilitiesBIAFW Shareholders’ equityBIAFW overview →